Last reviewed · How we verify
Chixiangshen Tongxin granules — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Chixiangshen Tongxin granules (Chixiangshen Tongxin granules) — Liaoning University of Traditional Chinese Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chixiangshen Tongxin granules TARGET | Chixiangshen Tongxin granules | Liaoning University of Traditional Chinese Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chixiangshen Tongxin granules CI watch — RSS
- Chixiangshen Tongxin granules CI watch — Atom
- Chixiangshen Tongxin granules CI watch — JSON
- Chixiangshen Tongxin granules alone — RSS
Cite this brief
Drug Landscape (2026). Chixiangshen Tongxin granules — Competitive Intelligence Brief. https://druglandscape.com/ci/chixiangshen-tongxin-granules. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab